2023 Q1 Form 10-Q Financial Statement

#000160706223000319 Filed on June 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $29.71K
YoY Change
Gross Profit -$29.71K
YoY Change
Gross Profit Margin
Selling, General & Admin $148.9K $64.53K $8.640K
YoY Change 1623.38% 140.34% -19.03%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.850K $0.00
YoY Change
% of Gross Profit
Operating Expenses $148.9K $64.53K $8.640K
YoY Change 1623.41% 140.34% -19.03%
Operating Profit -$148.9K -$94.24K -$8.636K
YoY Change 1624.21%
Interest Expense $10.64K $20.00 -$190.00
YoY Change -5701.05% -122.22% -102.26%
% of Operating Profit
Other Income/Expense, Net -$779.5K -$194.00
YoY Change 401702.58%
Pretax Income -$928.4K -$94.22K -$8.830K
YoY Change 10414.16% 249.87% 290.71%
Income Tax
% Of Pretax Income
Net Earnings -$928.4K -$94.22K -$8.830K
YoY Change 10414.16% 249.87% 290.88%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$258.60
COMMON SHARES
Basic Shares Outstanding 107.8M shares 35.95M shares 102.4M shares
Diluted Shares Outstanding 107.8M shares 102.4M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.56K $142.4K $3.120K
YoY Change 1552.56% 4162.57% 242.86%
Cash & Equivalents $51.56K $142.4K $3.120K
Short-Term Investments
Other Short-Term Assets $5.100K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $56.66K $142.4K $3.120K
YoY Change 1716.09% 4162.43% 242.86%
LONG-TERM ASSETS
Property, Plant & Equipment $172.9K $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $198.9K $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $56.66K $142.4K $3.120K
Total Long-Term Assets $198.9K $0.00 $0.00
Total Assets $255.5K $142.4K $3.120K
YoY Change 8089.68% 4162.43% 242.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.42K $37.87K $37.04K
YoY Change 95.52% -31.06% -89.65%
Accrued Expenses $61.62K $29.77K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $15.80K
YoY Change -100.0% -100.0% -98.08%
Long-Term Debt Due $35.59K $0.00
YoY Change
Total Short-Term Liabilities $112.0K $37.87K $113.5K
YoY Change -1.34% -63.91% -94.47%
LONG-TERM LIABILITIES
Long-Term Debt $893.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $893.0K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $112.0K $37.87K $113.5K
Total Long-Term Liabilities $893.0K $0.00 $0.00
Total Liabilities $1.005M $37.87K $113.5K
YoY Change 785.22% -63.91% -94.47%
SHAREHOLDERS EQUITY
Retained Earnings -$37.17M -$36.24M
YoY Change 0.42%
Common Stock $36.42M $36.35M
YoY Change 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.336K $3.336K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$749.5K $104.5K $110.4K
YoY Change
Total Liabilities & Shareholders Equity $255.5K $142.4K $3.120K
YoY Change 8089.68% 4162.43% 242.86%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$928.4K -$94.22K -$8.830K
YoY Change 10414.16% 249.87% 290.88%
Depreciation, Depletion And Amortization $5.850K $0.00
YoY Change
Cash From Operating Activities -$44.12K -$70.82K -$220.00
YoY Change 19952.27% 476.71% -94.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions -$4.089K $0.00
YoY Change
Other Investing Activities -$45.91K $0.00 $0.00
YoY Change
Cash From Investing Activities -$45.91K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$777.00 -820.0 0.000
YoY Change -105.26%
NET CHANGE
Cash From Operating Activities -$44.12K -70.82K -220.0
Cash From Investing Activities -45.91K 0.000 0.000
Cash From Financing Activities -$777.00 -820.0 0.000
Net Change In Cash -$44.89K -71.64K -220.0
YoY Change 20305.45% -2257.83% -94.62%
FREE CASH FLOW
Cash From Operating Activities -$44.12K -$70.82K -$220.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001113313
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
usd
CY2022Q1 us-gaap Depreciation
Depreciation
usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-30695
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ARVANA INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0618509
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
299 Main Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
CY2023Q1 dei City Area Code
CityAreaCode
(801)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
232-7395
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107839299 shares
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
51562 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
142365 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
5100 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
56662 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
142365 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172856 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
198856 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2023Q1 us-gaap Assets
Assets
255518 usd
CY2022Q4 us-gaap Assets
Assets
142365 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61615 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29770 usd
CY2023Q1 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
10800 usd
CY2022Q4 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
8100 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
35590 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
112005 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37870 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
892984 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
892984 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1004989 usd
CY2022Q4 us-gaap Liabilities
Liabilities
37870 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36314786 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36240352 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37168768 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36240368 usd
CY2023Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-746135 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
107831 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6255 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-749471 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104495 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
255518 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142365 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
112440 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3292 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
36463 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
5344 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
148903 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
8636 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-148903 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8636 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
8000 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
5850 usd
CY2022Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
-0 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
4 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
10642 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
194 usd
CY2023Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-779497 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-194 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-928400 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8830 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
102445554 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102445554 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-101585 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8830 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-110415 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104495 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
74434 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-928400 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-749471 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-928400 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8830 usd
CY2023Q1 us-gaap Depreciation
Depreciation
5850 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
74434 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18792 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5764 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
10200 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2844 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44115 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-222 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
50000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-4089 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
CY2023Q1 us-gaap Payments For Loans
PaymentsForLoans
777 usd
CY2022Q1 us-gaap Payments For Loans
PaymentsForLoans
-0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-777 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-90803 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-222 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142365 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3340 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51562 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3118 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2856 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 AVNI Acquisition
Acquisition
700000 usd
CY2022Q1 AVNI Acquisition
Acquisition
0 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
234904 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-0 usd
CY2023Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
172856 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
0 usd
CY2023Q1 us-gaap Depreciation
Depreciation
5850 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_z7HLDBnul9e4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_86A_zsjHt9ldGeQc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation consolidated of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zRkhFYEkyHFf" style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_86F_zidAaK35uZV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. At March 31, 2023 and December 31, 2022 respectively, the Company did not have any cash in excess of the insured FDIC limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
11864 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7950000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-928400 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37168768 usd
CY2023Q1 AVNI Working Capital
WorkingCapital
55343 usd
CY2023Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
12736 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
4089 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
5100 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
178706 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Commercial Fishing License
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommercialFishingLicense
26000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
213895 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
4910 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
644 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Payable To Affiliates
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayableToAffiliates
62634 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable
166716 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
234904 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
750000 usd
CY2023Q1 AVNI Business Combination Loss On Asset Acquisition
BusinessCombinationLossOnAssetAcquisition
771009 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
178706 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
0 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5850 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
4000 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
8000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
48000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
48000 usd
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
4800000 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.07
CY2022Q4 AVNI Restricted Common Stock Total Proceeds
RestrictedCommonStockTotalProceeds
320000 usd
CY2022 AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
32237 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
111153 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
928574 usd
CY2023Q1 AVNI Accrued Payroll Included In Amounts Due To Related Parties
AccruedPayrollIncludedInAmountsDueToRelatedParties
10000 usd
CY2022Q4 AVNI Accrued Payroll Included In Amounts Due To Related Parties
AccruedPayrollIncludedInAmountsDueToRelatedParties
7500 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
800 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
600 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7950000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
74434 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q1 AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
597688 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
187464 shares
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
239421 shares
CY2025Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
156902 shares
CY2026Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7582 shares
CY2027Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6319 shares
CY2023Q1 AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
597688 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
928574 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
35590 usd
CY2023Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
892984 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
35590 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
10294 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
746937 usd

Files In Submission

Name View Source Status
0001607062-23-000319-index-headers.html Edgar Link pending
0001607062-23-000319-index.html Edgar Link pending
0001607062-23-000319.txt Edgar Link pending
0001607062-23-000319-xbrl.zip Edgar Link pending
avni-20230331.xsd Edgar Link pending
avni033123form10q.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
avni-20230331_cal.xml Edgar Link unprocessable
avni-20230331_def.xml Edgar Link unprocessable
avni-20230331_pre.xml Edgar Link unprocessable
avni-20230331_lab.xml Edgar Link unprocessable
avni033123form10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable